Rankings
▼
Calendar
LXRX Q4 2024 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
LXRX
Lexicon Pharmaceuticals, Inc.
$704M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$27M
+3682.6% YoY
Gross Profit
$621,000
2.3% margin
Operating Income
-$33M
-123.3% margin
Net Income
-$34M
-127.2% margin
EPS (Diluted)
$-0.09
QoQ Revenue Growth
+1417.4%
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$22M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$298M
Total Liabilities
$152M
Stockholders' Equity
$146M
Cash & Equivalents
$67M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$27M
$702,000
+3682.6%
Gross Profit
$621,000
-$14M
+104.4%
Operating Income
-$33M
-$47M
+30.0%
Net Income
-$34M
-$50M
+32.1%
← FY 2024
All Quarters
Q1 2025 →